Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs KIMIA BIOSCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. KIMIA BIOSCIENCES MARKSANS PHARMA./
KIMIA BIOSCIENCES
 
P/E (TTM) x 40.3 -189.1 - View Chart
P/BV x 6.8 40.1 16.9% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 MARKSANS PHARMA.   KIMIA BIOSCIENCES
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-24
KIMIA BIOSCIENCES
Mar-23
MARKSANS PHARMA./
KIMIA BIOSCIENCES
5-Yr Chart
Click to enlarge
High Rs17953 337.9%   
Low Rs7030 230.2%   
Sales per share (Unadj.) Rs48.027.2 176.9%  
Earnings per share (Unadj.) Rs6.9-2.0 -351.5%  
Cash flow per share (Unadj.) Rs8.6-1.3 -674.9%  
Dividends per share (Unadj.) Rs0.600-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs45.61.2 3,946.4%  
Shares outstanding (eoy) m453.1647.31 957.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.61.5 168.9%   
Avg P/E ratio x17.9-21.0 -85.0%  
P/CF ratio (eoy) x14.5-32.7 -44.3%  
Price / Book Value ratio x2.736.0 7.6%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m56,3331,968 2,862.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,936164 1,790.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m21,7741,285 1,694.3%  
Other income Rs m50413 3,788.3%   
Total revenues Rs m22,2781,298 1,715.7%   
Gross profit Rs m4,586-61 -7,467.5%  
Depreciation Rs m74333 2,229.0%   
Interest Rs m11242 263.9%   
Profit before tax Rs m4,235-124 -3,418.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,086-30 -3,578.1%   
Profit after tax Rs m3,149-94 -3,367.1%  
Gross profit margin %21.1-4.8 -440.7%  
Effective tax rate %25.624.5 104.7%   
Net profit margin %14.5-7.3 -198.7%  
BALANCE SHEET DATA
Current assets Rs m18,625827 2,250.8%   
Current liabilities Rs m3,898764 510.3%   
Net working cap to sales %67.64.9 1,368.9%  
Current ratio x4.81.1 441.1%  
Inventory Days Days101 830.8%  
Debtors Days Days76869 8.7%  
Net fixed assets Rs m8,185346 2,365.4%   
Share capital Rs m45347 957.9%   
"Free" reserves Rs m20,1977 275,920.5%   
Net worth Rs m20,65155 37,800.7%   
Long term debt Rs m0308 0.0%   
Total assets Rs m26,8101,173 2,284.6%  
Interest coverage x38.8-1.9 -2,022.9%   
Debt to equity ratio x05.6 0.0%  
Sales to assets ratio x0.81.1 74.2%   
Return on assets %12.2-4.4 -279.5%  
Return on equity %15.2-171.2 -8.9%  
Return on capital %21.1-22.4 -93.8%  
Exports to sales %00-   
Imports to sales %6.90-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,511NA-   
Fx inflow Rs m8,4660-   
Fx outflow Rs m1,5110-   
Net fx Rs m6,9540-   
CASH FLOW
From Operations Rs m2,304-68 -3,403.4%  
From Investments Rs m-1,408-28 5,031.8%  
From Financial Activity Rs m-68795 -720.3%  
Net Cashflow Rs m2080 -77,185.2%  

Share Holding

Indian Promoters % 43.9 74.9 58.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.4 0.4 6,686.8%  
FIIs % 21.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 56.1 25.1 224.0%  
Shareholders   248,845 12,179 2,043.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on MARKSANS PHARMA. vs KIMIA BIOSCIENCES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs KIMIA BIOSCIENCES Share Price Performance

Period MARKSANS PHARMA. KIMIA BIOSCIENCES S&P BSE HEALTHCARE
1-Day 1.03% -1.47% 0.11%
1-Month 12.57% -6.01% -3.22%
1-Year 122.38% 23.44% 42.65%
3-Year CAGR 78.81% 4.73% 19.86%
5-Year CAGR 83.14% 13.66% 25.90%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the KIMIA BIOSCIENCES share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of KIMIA BIOSCIENCES the stake stands at 74.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of KIMIA BIOSCIENCES.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.6 per share. This amounted to a Dividend Payout ratio of 8.6%.

KIMIA BIOSCIENCES paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of KIMIA BIOSCIENCES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.